Financial

Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination

Financial by Comments are Disabled

TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) — Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“the “Resulting Issuer” or the “Corporation”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the previously announced business combination between Conavi Medical Inc. (“Conavi”) and the Corporation in an all-stock transaction, which constituted a reverse takeover of the Corporation (the “Transaction”). The combined company (the Resulting Issuer) will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.

Continue Reading →

BON SECOURS MERCY HEALTH, ALIGNEDCARDIO AND COMPASS SURGICAL PARTNERS TO OPEN STATE-OF-THE-ART CARDIOVASCULAR SURGERY CENTER IN HENRICO, VIRGINIA

Financial by Comments are Disabled

HENRICO, Va. and RALEIGH, N.C., Oct. 8, 2024 /PRNewswire/ — Compass Surgical Partners, Bon Secours Mercy Health and AlignedCardio today announced their plans to open Short Pump Cardiovascular Ambulatory Surgery Center in the Short Pump area of Henrico, Virginia. Scheduled to open in late…

Continue Reading →

CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

Financial by Comments are Disabled

BERKELEY HEIGHTS, N.J., Oct. 08, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a new commercial supply contract with a top-five mid-sized dialysis operator for the supply of DefenCath® (taurolidine and heparin) to dialysis clinics in the US. This new agreement will provide access to DefenCath for adult patients with kidney failure receiving hemodialysis through a central venous catheter at more than 200 outpatient dialysis clinics located across the United States.

Continue Reading →

Inari Medical to Announce Third Quarter 2024 Financial Results

Financial by Comments are Disabled

IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its third quarter 2024 financial results on Monday, October 28, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Continue Reading →

InterVene, Inc. Announces $13 Million Series A Financing to Advance Recana™ System Through US Market Clearance

Financial by 0 comments

October 07, 2024 08:00 AM Eastern Daylight Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–InterVene, Inc., a clinical-stage medical device company dedicated to developing interventional solutions for chronic venous insufficiency (CVI), announced today the closing of its $13M Series A financing round. The financing was co-led by new investor Treo Ventures and existing […]

Continue Reading →

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

Financial by 0 comments

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the first quarter of fiscal year 2025, which ended August […]

Continue Reading →
1 … 74 75 76 77 78 … 494